Neoantigen Dendritic Cell Vaccine Therapy is a personalized cancer treatment method. This therapy activates the patient's immune system to recognize and attack cancer cells. First, a sample is taken from the patient's blood to analyze the genes of the cancer cells and identify unique mutation markers called neoantigens. Next, dendritic cells, which act as "commanders" in the immune system, are extracted from the patient's blood. In the laboratory, these dendritic cells are combined with the neoantigens to learn to recognize the cancer cells' characteristics. The trained dendritic cells are then made into a vaccine and injected back into the patient's body. Once inside, these dendritic cells activate the immune system, teaching other immune cells how to recognize and attack cancer cells carrying these neoantigens. Through this personalized immune system training, the patient's body can more effectively fight cancer, reduce the impact on healthy cells, and improve the treatment's targeting and effectiveness.